Sanford C. Bernstein reiterated their buy rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a research note published on Monday morning, TipRanks reports. They currently have a $625.00 target price on the medical equipment provider’s stock.
Other analysts also recently issued research reports about the company. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $565.00 to $600.00 and gave the company an overweight rating in a research note on Thursday, June 18th. Oppenheimer reissued a sell rating and set a $365.00 target price on shares of Intuitive Surgical in a research note on Tuesday, April 28th. Deutsche Bank decreased their target price on Intuitive Surgical from $595.00 to $500.00 and set a hold rating on the stock in a research note on Friday, April 17th. Morgan Stanley reduced their price objective on Intuitive Surgical from $670.00 to $622.00 and set an overweight rating on the stock in a research note on Friday, March 27th. Finally, Wells Fargo & Co lifted their price objective on Intuitive Surgical from $561.00 to $632.00 and gave the stock an overweight rating in a research note on Thursday, June 4th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of $583.21.
ISRG stock opened at $607.80 on Monday. Intuitive Surgical has a twelve month low of $360.50 and a twelve month high of $619.00. The stock has a market cap of $68.26 billion, a P/E ratio of 52.35, a PEG ratio of 13.33 and a beta of 0.93. The business’s 50-day moving average price is $574.24 and its 200-day moving average price is $549.08.
Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 16th. The medical equipment provider reported $2.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.54 by $0.15. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.01 billion. Intuitive Surgical had a return on equity of 17.40% and a net margin of 30.11%. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the company earned $2.61 EPS. As a group, equities analysts forecast that Intuitive Surgical will post 6.74 earnings per share for the current year.
In related news, SVP Jamie Samath sold 248 shares of the business’s stock in a transaction on Tuesday, April 21st. The stock was sold at an average price of $506.18, for a total transaction of $125,532.64. Following the completion of the transaction, the senior vice president now owns 385 shares in the company, valued at approximately $194,879.30. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP David J. Rosa sold 17,950 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $553.49, for a total value of $9,935,145.50. Following the completion of the sale, the executive vice president now owns 37,269 shares of the company’s stock, valued at $20,628,018.81. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,223 shares of company stock valued at $18,611,408. 1.60% of the stock is owned by company insiders.
Hedge funds have recently modified their holdings of the business. TFG Advisers LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth $25,000. 1776 Wealth LLC lifted its holdings in shares of Intuitive Surgical by 72.2% in the 1st quarter. 1776 Wealth LLC now owns 62 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 26 shares during the period. Red Door Wealth Management LLC bought a new position in shares of Intuitive Surgical in the 1st quarter worth $33,000. Gemmer Asset Management LLC raised its position in shares of Intuitive Surgical by 89.7% in the 1st quarter. Gemmer Asset Management LLC now owns 74 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 35 shares in the last quarter. Finally, Ellis Investment Partners LLC raised its position in shares of Intuitive Surgical by 66.7% in the 1st quarter. Ellis Investment Partners LLC now owns 100 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 40 shares in the last quarter. Institutional investors and hedge funds own 87.24% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Article: Consumer behavior in bull markets
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.